Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis - McAlpine - 2021 - Cancer - Wiley Online Library
Luca FUSO | Md phD | Ospedale Ordine Mauriziano di Torino, Umberto I, Turin | Gynaecology oncology | Research profile
Gynecologic Oncology | Abstracts for the 2021 Society of Gynecologic Oncology 52nd Annual Meeting on Women's Cancer | ScienceDirect.com by Elsevier
Dr. Rebecca Sutphen, MD | Tampa, FL | Clinical Geneticist | US News Doctors
Dr. Douglas A. Levine, MD | New York, NY | Obstetrician-Gynecologist | US News Doctors
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus | Nature Communications
Dr. Beth Karlan, MD | Los Angeles, CA | Obstetrician-Gynecologist | US News Doctors
Dr. Banu K. Arun, MD | Houston, TX | Oncologist | US News Doctors
Dr. Rebecca Sutphen, MD | Tampa, FL | Clinical Geneticist | US News Doctors
Cancers | Free Full-Text | MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer
D.4. ECRD 2018 Vienna Responsible: Sharon Ashton Supervising: Yann Le Cam A.1.5. Provide a platform for multi-stakeholder dial
Dr. Michael E. Carney, MD | Honolulu, HI | Obstetrician-Gynecologist | US News Doctors
Jean-Emmanuel KURTZ | Medical Doctor | MD, PhD | CHRU de Strasbourg, Strasbourg | CHRU strasbourg | Pôle Onco-hématologie | Research profile
Volume 7, Issue 43 | Oncotarget
Synthetic Lethality through the Lens of Medicinal Chemistry | Journal of Medicinal Chemistry
Synthetic Lethality through the Lens of Medicinal Chemistry | Journal of Medicinal Chemistry
Synthetic Lethality through the Lens of Medicinal Chemistry | Journal of Medicinal Chemistry
JCM | May-1 2022 - Browse Articles
ΚΗΔΕΙΑ ΣΤΕΦΑΝΙΑ ΟΛΙΒΙΑ ΒΕΡΓΩΤΗ – Voutospress Kefalonia
Dr. Beth Karlan, MD | Los Angeles, CA | Obstetrician-Gynecologist | US News Doctors
